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Abstract
Background: Adverse effects of high-fat diets (HFD) on metabolic homeostasis are linked to adipose tissue
dysfunction. The goal of this study was to examine the effect of the HFD nature on adipose tissue activity,
metabolic disturbances and glucose homeostasis alterations in male mice compared with female mice.
Methods: C57BL/6J mice were fed either a chow diet or HFD including vegetal (VD) or animal (AD) fat. Body
weight, plasmatic parameters and adipose tissue mRNA expression levels of key genes were evaluated after 20
weeks of HFD feeding.
Results: HFD-fed mice were significantly heavier than control at the end of the protocol. Greater abdominal
visceral fat accumulation was observed in mice fed with AD compared to those fed a chow diet or VD. Correlated
with weight gain, leptin levels in systemic circulation were increased in HFD-fed mice in both sexes with a
significant higher level in AD group compared to VD group. Circulating adiponectin levels as well as adipose tissue
mRNA expression levels were significantly decreased in HFD-fed male mice. Although its plasma levels remained
unchanged in females, adiponectin mRNA levels were significantly reduced in adipose tissue of both HFD-fed
groups with a more marked decrease in AD group compared to VD group. Only HFD-fed male mice were diabetic
with increased fasting glycaemia. On the other hand, insulin levels were only increased in AD-fed group in both
sexes associated with increased resistin levels. VD did not induce any apparent metabolic alteration in females
despite the increased weight gain. Peroxisome Proliferator-Activated Receptors gamma-2 (PPARg2) and estrogen
receptor alpha (ERa) mRNA expression levels in adipose tissue were decreased up to 70% in HFD-fed mice but
were more markedly reduced in male mice as compared with female mice.
Conclusions: The nature of dietary fat determines the extent of metabolic alterations reflected in adipocytes
through modifications in the pattern of adipokines secretion and modulation of key genes mRNA expression.
Compared with males, female mice demonstrate higher capacity in controlling glucose homeostasis in response to
20 weeks HFD feeding. Our data suggest gender specific interactions between the diet’s fatty acid source, the
adipocyte-secreted proteins and metabolic disorders.
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Obesity is defined as an increase of adipose tissue mass
in the body and its accumulation in peripheral organs
that leads to metabolic abnormalities such as type 2 dia-
betes (T2D), insulin resistance and hyperlepidemia [1,2].
Obesity is thus a worldwide healthcare problem increas-
ing morbid-mortality [2].
The visceral adipose tissue plays an important role in
the regulation of postprandial lipid and glucose systemic
homeostasis by targeting essential organs (adipose tissue,
muscle, etc.) and systems (neuroendocrine axis, etc.)
[3-6]. It is considered as a secretory gland source of sev-
eral bioactive peptides called adipokines [6]. Thus, adi-
pose tissue becomes a major protagonist of metabolic
alterations triggered by lipid over-accumulation in their
cytoplasmic droplet which leads to adipocytes function
disorders [7,8]. An alteration in the adipokine secretion
profile leads to insulin resistance, glucose intolerance
and lipid metabolic disturbances [8-10].
Consumption of High-fat diets (HFD) is a central risk
factor for metabolic disorders linked to obesity [9,11].
Adverse effects of HFD on metabolic homeostasis are
linked to adipose tissue physiology and are highly influ-
enced by gender [12,13]. The imbalance between caloric
intake and energy expenditure leads to hyperplasia and
hypertrophy of adipocytes depending on the type as
much as the amount of dietary lipids [14,15].
Numerous factors regulate the adipose tissue activity
including adipocyte-specific genes such as peroxisome
proliferator-activated receptors gamma (PPARg)[ 1 6 ] .
Dietary fatty acids (FA) and their derivatives are
described as PPARg ligands that trigger physiological
responses such as adipogenesis and adipokine secretion.
Thus, HFD-inducing metabolic disorders act via PPARg
to induce different levels of systemic homeostatic
remodelling.
Appreciating the pathogenesis of HFD-induced meta-
bolic disorders requires a thorough knowledge of adi-
pose tissue physiology and the regulation of adipokines
secretion and action including the role of gender in
response to these parameters.
Thus, significant progress has been made in our
understanding of the relation between HFD feeding and
adipose tissue dysfunction. However, experimental evi-
dence for HFD-mediating metabolic alterations remains
to be elucidated. Therefore, we propose a possible role
for HFDs’ fat nature on the establishment of metabolic
disorders. Herein, we evaluated the impact of FA nature
on the development of metabolic alterations through
modulation of adipose tissue activity and secretion pro-
files. We also determined gender-specific impact on the
kinetic of metabolic disorders progression in response to
these diets.
Methods
Experimental protocol
The animal protocol was approved by the Animal Care
and Use Committee of the Montreal Heart Institute
conforming to the Guide for the Care and Use of
Laboratory Animals published by the US National Insti-
tutes of Health (NIH Publication No. 85-23, revised
1996). Three groups of 10 male and 10 female C57BL/6J
mice (Jackson Laboratory, Bar Harbor, MN, USA) were
included in this study at 5 weeks of age. Each group was
fed either standard diet (SD) used as control (6% fat,
57% sucrose) or one of the two low cholesterol HFD
(34.9% fat, 26.3% sucrose) (detailed composition pre-
sented in Table 1). These latter were iso-caloric but dif-
fered in fat nature: VD was composed of soy and cotton
oil while AD was composed of lard. Weight gain was
monitored during the 20 weeks of protocol and daily
food consumption was calculated by subtracting the
residual quantity from the supplemented food quantity
each day. Energy intake was calculated on the basis of
3.8 kcal/g for the SD and 5.2 kcal/g for both HFD.
Table 1 Analysis of diets compositions
Supplier
Cat#
ResearchDiet
D06061202
ResearchDiet
D12492
Harlan-
Teklad
2018
Components VD AD SD
Sucrose 26,3% 26,3% 57%
Protein 26,2% 26,2% 18,9%
Lipid 34,9% 34,9% 6%
FA composition: g/100 g of diet
C14 Myristic 0,2 0,9 0,006
C14:1 Myristoleic 0 0,5 0
C16 Palmitic 13,0 21,8 0,764
C16:1 Palmitoleic 0,2 3,8 0
C18 Stearic 10,2 12,4 0,15
C18:1 Oleic 62,0 39,3 1,26
C18:2 Linoleic 12,9 12,8 3,13
C18:3 Linolenic 0,7 1,6 0,28
C20 Arachidic 0,3 0 0,01
C20:4 Arachidonic 0 1,7 0
C22 Behenic 0,3 0 0,003
C24 Lignoceric 0,1 0 0
Cholesterol 0,035 0,030
FA proportions: Percentage of total FA
Saturated FA 24,2% 37,0% 16,96%
Mono-unsaturated
FA
62,2% 46,0% 22,71%
Poly-unsaturated FA 13,6% 17,0% 60,33%
provided by the manufacturer (Research Diets, Inc).
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The Intra-Peritoneal Glucose Tolerance Test (IPGTT)
was performed after 20 weeks of diet following over-
night (18 hr) fasting. After measuring the fasting glycæ-
mia using an Accu-Check
® (Roche Diagnostics, Laval,
QC, Canada) glucometer, mice received an intra-perito-
neal injection of glucose solution (2 g/kg). Subsequent
measures of plasma glucose levels were performed 30,
60, 90, 120 and 180 minutes post-injection. The area
under the glucose tolerance curve (AUC) was measured
to evaluate mice glucose tolerance.
Physiological analyses
Non-invasive measurement of mice cardiac function was
performed by Doppler echocardiography under anesthe-
sia (isoflurane 2.5%). The velocities of the early mitral
flow (E) over the late mitral flow (A) were measured
with a Doppler Signal Processing Workstation (GE-
Ultrasound System). An increase in the E/A ratio, with
restrictive aspect of transmitral flow (E/A > 2) indicated
a diastolic dysfunction with increased LV filling pres-
sure. To calculate ventricular mass, left ventricular (LV)
tele-diastolic diameter, posterior wall and inter-ventricu-
lar septum thickness were measured.
Biochemical analyses
At sacrifice, after an overnight fast (18 hr), blood sam-
ples were gathered by cardiac exsanguinations and
plasma was collected and stored at -20°C until analysis.
Plasma adiponectin and leptin concentrations were
measured using mouse ELISA kits (ALPCO, Salem,
NH, USA) according to the manufacturer’si n s t r u c -
tions. Plasma insulin, resistin and TNFa levels were
analyzed using mouse ELISA kits (AssayPro, St.
Charles, MO, USA) according to the manufacturer’s
instructions. All measurements were analyzed in dupli-
cate for at least 8 animals per group. The circulating
concentrations of FA in mice serum were evaluated
using ADIFAB free FA indicator (Invitrogen, Burling-
ton, ON, Canada).
Homeostasis model assessment of insulin resistance
(HOMA-IR)
Insulin resistance was assessed by calculation of
HOMA-IR using glucose and insulin concentrations
obtained after overnight fasting (18 hr), using the fol-
lowing formula:
HOMA−IR

mmol/L × µU/ml

= [fasting glucose (mM)× fasting insulin

µU/ml

]/22.5
HOMA-IR is known to be correlated with the insulin
sensitivity evaluated by the euglycemic hyperinsulinemic
clamp [17,18].
Quantitative real-time PCR (Q-PCR)
At sacrifice, mouse adipose tissue was removed from the
abdominal visceral region weighed to evaluate its accu-
mulation level, and then frozen until mRNA extraction.
Total RNA was isolated from approximately 30 mg of
frozen white adipose tissue of the abdominal visceral
region using Qiazol reagent according to the manufac-
turer’s instructions (Qiagen, Toronto, ON, Canada). Sin-
gle-strand cDNA was synthesized according to the
procedure in the iScript cDNA Synthesis Kit manual
(Bio-Rad Laboratories, Montreal, QC, Canada). Q-PCR
reactions were carried out using the Brilliant-II SYBR
®
Green Master-Mix (Stratagene, Mississauga, ON,
Canada) and specific primers:
￿ Adiponectin primers (#GenBank: NM_009605.4):
○ Fwd 5’-GAA-TCA-TTA-TGA-CGG-CAG-CA-
3’
○ Rev 5’-TCA-TGT-ACA-CCG-TGA-TGT-
GGT-A-3’
￿ Leptin primers (#GenBank: NM_008493.3):
○ Fwd 5’-GAC-ATT-TCA-CAC-AGG-CAG-
TCG-3’
○ Rev 5’-GCA-AGC-TGG-TGA-GGA-TCT-GT-
3’
￿ TNFa primers (#GenBank: NM_013693.2):
○ Fwd 5’-CAT-CTT-CTC-AAA-ATT-CGA-
GTG-ACA-A-3’
○ Rev 5’-TGG-GAG-TAG-ACA-AGG-TAC-
AAC-CC-3’
￿ PPARg2 primers (#GenBank: NM_011146.3):
○ Fwd 5’-AGC-ATG-GTG-CCT-TCG-CTG-AT-
3’
○ Rev 5’-GGT-GGA-GAT-GCA-GGT-TCT-AC-
3’
￿ ERa primers (#GenBank: NM_007956.4):
○ Fwd 5’-TCT-GAC-AAT-CGA-CGC-CAG-AA-
3’
○ Rev 5’-TAA-CAC-TTG-CGC-AGC-CGA-CA-
3’
The mRNA levels were normalized to Cyclophilin-A
expression levels (Fwd 5’-CCG-ATG-ACG-AGC-CCT-
TGG-3’;R e v5 ’-GCC-GCC-AGT-GCC-ATT-ATG-3’).
The targeted and referenced genes were amplified in
duplicate in the same run using the Mx3000P Q-PCR
System (Stratagene).
The relative quantification of target genes was deter-
mined using the MxProTM Q-PCR software version
3.00 (Strategene). Briefly, Ct average of each duplicate
was calculated for each gene and Cyclophilin-A and the
ΔCT (CTgene - CTCyclo-A) was determined. The
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sample and set as 100% of gene quantity. Finally, the
mRNA abundance of other samples to the mRNA abun-
dance of the control adipose tissue was calculated with
use of the formula 2
-ΔΔCT.
Statistical Analyses
All statistical analyses were performed separately for
males and females.
Data are presented as mean ± standard deviation for
continuous variables. Repeated measures analysis of cov-
ariance (ANCOVA) model was used to study weight
gain across the study time and between groups (SD, VD
and AD groups) adjusted for baseline weight value. The
group × time interaction was also included in the
ANCOVA model and comparisons between groups at a
given time point were undertaken only in the presence
of a significant group × time interaction. Otherwise, glo-
bal conclusions were drawn based on the main time and
group effects of the model.
Repeated measures analysis of variance (ANOVA)
models were used to study the glycemic parameters
across the IPGTT time (0, 30, 60, 90, 120 and 180 min)
and between groups. Models with time, group and
group × time interaction as independent variables were
used. Comparisons between groups at a given time-
point were undertaken only in the presence of signifi-
cant group × time interaction. Otherwise, global conclu-
sions were drawn based on the main time and group
effects of the model.
The insulin, adiponectin, leptin, TNFa and FA levels
were compared between groups (SD, VD and AD
groups) using an ANOVA model.
In addition, the relationships among weight gain, car-
diac parameters and metabolic parameters were investi-
gated using Pearson or Spearman correlations according
to the nature of the data distribution.
All analyses were done using SAS version 9.1 (SAS
Institute Inc., Cary, NC, USA) and conducted at the
0.05 significance level.
Results
Weight gain and adipose tissue mass
After 20 weeks of diet, the mean weight in SD group
had increased by 64% in males compared to their weight
at the beginning of the protocol (Figure 1.A). A more
pronounced increase was observed in VD (150%, P <
0.001) and AD groups (144%, P < 0.001). Comparable
results were obtained in females fed with VD (116%)
a n dA D( 1 3 7 % )c o m p a r e dt ot h eS Dg r o u p( 3 9 % ,P<
0.001) (Figure 1.B). Despite the differences in weight
gain, the daily food intake (kCal/day/mouse) was similar
in both sexes notwithstanding the different diets (Figure
1.C).
However, the weight gain observed in HFD groups did
not reflect comparable amounts of adipose tissue accu-
mulation in the abdominal visceral region (Figure 1.D).
We showed that male and female mice under SD accu-
mulated 3.9 g and 2.3 g respectively after 20 weeks of
diet. For the same feeding time, considerable increase
was seen in adipose tissue mass in male and female
mice under VD (8.4 g and 4.9 g respectively) and AD
(15.2 g and 11.2 g respectively) compared to SD group
(P < 0.01). In the HFD group, for a similar weight gain,
abdominal-visceral adipose tissue constituted 37.4% of
t o t a lb o d yw e i g h ti nm a l em i c eu n d e rA D ;a2 - f o l d
increase as compared to the VD group (17.8%, P <
0.001) and a 3-fold increase in comparison with the SD
group (12.9%, P < 0.001). Similar results were obtained
in females (10.6% for SD group; 14.0% for VD group;
26.0% for AD group) (P < 0.001).
Glycemic parameters
The IPGTT showed a glycæmia peak 30 min post-chal-
lenge in the SD male group (Figure 2.A). Glucose elimi-
nation followed first order kinetic curve thereafter to
reach basal level after 180 minutes. Both HFD groups
showed an equivalent glucose elimination kinetic curve
with higher blood glucose levels throughout the dura-
tion of the test. This led to an increased AUC in these
groups (45.5 for VD, 44.6 for AD) compared to SD
(28.6, P < 0.001) (Figure 2.C). In contrast to male
groups, female groups responded such that only AD
showed an increased glycæmia 30 min post-challenge
Figure 1 K i n e t i co fw e i g h tg a i ni nm a l e( A )a n df e m a l e( B )
mice (n = 10). The mean cumulative food intake (C) was evaluated
during the protocol in g/day/mouse (white column) and kCal/day/
mouse (hatched column). White fat pad mass (D) is expressed as
the weight of adipose tissue extracted from the abdominal visceral
region of each mouse (white column) and transposed in
percentage of total body weight (hatched column) at the time of
the sacrifice (n = 9). * P < 0.05, ** P < 0.01, *** P < 0.001 vs. SD; ###
P < 0.001 vs. VD.
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an increased AUC (41.0) compared to SD (36.3, P <
0.01) (Figure 2.C). AUC of the VD female group
remained unchanged (39.4).
Both HFD male groups had an increased fasting gly-
cæmia (Figure 2.D) and are therefore considered dia-
betic in addition to being glucose intolerant. In contrast
no change in fasting glycæmia was observed in the
female groups.
Biochemical blood analysis
Insulin concentration was significantly increased in AD
male (0.67 μg/ml) and female (0.72 μg/ml) groups com-
pared to SD group (0.33 μg/ml for male, P < 0.01; 0.40
μg/ml for female, P < 0.01), and VD group (0.40 μg/ml
for male, P < 0.05; 0.25 μg/ml for female, (P < 0.001)
(Figure 3.A). These results emphasize the T2D state of
AD male mice shown to have developed glucose intoler-
ance and increased fasting glycæmia. Furthermore, the
HOMA-IR factor, reflecting the insulin resistance, was
also significantly increased in the AD group (Figure 3.B).
Circulating FA levels were highly increased in HFD
groups for both genders (P < 0.01) (Figure 3.C). HFD
raised circulating FA by 130% in males (1.13 μMf o r
VD, 1.18 μM for AD) and up to 200% in females (0.97
μM for VD, 1.15 μM for AD) compared to their respec-
tive control (0.50 μMf o rm a l e ,0 . 3 8μM for female),
without significant differences between HFD groups.
Adipokine secretion profiles in mice blood were evalu-
ated. A marked increase in resistin levels (P < 0.05) was
measured in AD groups (161.9 ng/ml for males and
135.6 ng/ml for females) compared to SD and VD
groups (P < 0.05) (Figure 3.D). Interestingly, resistin
levels were significantly higher in females under SD
(111.2 ng/ml) and VD (114.4 ng/ml) compared to the
corresponding male groups (89.8 ng/ml; 94.6 ng/ml
respectively) (P < 0.05).
High levels of leptin were found in both VD (575.0
ng/ml) and AD (801.1 ng/ml) male groups compared to
SD group (57.8 ng/ml), with a 40% higher level in AD
vs. VD groups (P < 0.001) (Figure 3.E). A comparable
hyperleptinemia profile was detected in females under
HFD compared to the control group (42.4 ng/ml) with a
more marked difference (166%) between VD (341.1 ng/
ml) and AD (908.0 ng/ml) groups (P < 0.001).
On the other hand, circulating adiponectin was
decreased in male mice of VD (1.4 μg/ml) and AD (1.2
μg/ml) groups compared to control (2.0 μg/ml, P < 0.001),
an effect not observed among female groups (Figure 2.F).
Moreover, females presented a 5 to 7-fold higher adipo-
nectinemia than corresponding male groups (P < 0.001).
Finally, TNFa circulating levels remained unchanged
in males and females of the different diet groups (data
not shown).
Adipokine mRNA expression levels
Adipokine mRNA expression levels were evaluated in
the adipose tissue obtained from the abdominal visceral
region.
A marked decrease in adiponectin mRNA levels (P <
0.001) was measured in white adipose tissue of VD male
(0.54) and female (4.53) groups and AD male (0.61) and
female (2.84) groups compared to control (1.24 for
males and 15.67 for females) (Figure 4.A). This decrease
was more pronounced in the AD female group com-
pared to the VD group (P < 0.05). Overall, adiponectin
mRNA levels in HFD-fed females remained 5 to 12
times higher than levels in HFD-fed males.
As seen in blood protein levels, leptin mRNA levels
were also significantly increased in white adipose tissue
of HFD male mice (3.93 for VD and 5.39 for AD group)
compared to control (0.78) (P < 0.001) with no differ-
ence between the two HFD groups (Figure 4.B). In
females, on the other hand, VD increased leptin mRNA
levels slightly in visceral adipose tissue (2.49) compared
to control (0.88) (P < 0.05) though AD showed a more
marked increase of leptin mRNA (5.37) compared to SD
(P < 0.001) and VD (P < 0.001).
We then evaluated mRNA expression levels of
PPARg2, nuclear receptors implicated in adipokine tran-
scription control. HFD significantly reduced PPARg2
mRNA expression in males fed with VD (0.34) and AD
(0.21), and in females fed with VD (0.65) and AD (0.46)
compared to control (P < 0.001) (Figure 4.C). However,
PPARg2 expression levels remained up to 2-times super-
ior in the abdominal visceral adipose tissue of females
compared to the corresponding male groups.
Figure 2 Glycemic parameters. After overnight fasting, IPGTT
challenge was carried at the end of the protocol in males (A) and
females (B) (n = 9). From these curves, AUC were calculated to
estimate glucose tolerance in corresponding mice (C). Fasting
glycæmia (D) was measured at the beginning of the IPGTT. * P <
0.05, *** P < 0.001 vs. SD.
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Page 5 of 11Figure 3 Circulating levels of insulin (A), FA (C), resistin (D) leptin (E) and adiponectin (F) circulating levels were evaluated at the
sacrifice after overnight fasting in all mice groups (n = 8). HOMA-IR (B) was calculated according to fasting glycæmia and insulinæmia
using the following formula: HOMA-IR (mmol/L × μU/ml) = fasting glucose (mM) × fasting insulin (μU/ml)/22.5. * P < 0.05, ** P < 0.01, *** P <
0.001 vs. SD; # P < 0.05, ## P < 0.01, ### P < 0.001 vs. VD.
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estrogens receptors (ER) and PPARg regulatory path-
ways [16], we evaluated the mRNA expression levels of
its alpha subtype (ERa). ERa mRNA expression was
down-regulated by 70% in male HFD groups and 50% in
female HFD groups compared to control (P < 0.001)
(Figure 4.D). No diet-specific difference was detected
between HFD groups but ERa mRNA expression was 3
times higher in females compared to the corresponding
male groups.
Finally, TNFa mRNA expression levels were
unchanged in white adipose tissue in female groups
compared to control, but were significantly increased in
males fed with AD (24.90) compared to control (2.25)
(P < 0.01), but not in VD (9.20) (Additional file 1: Figure
S1).
Cardiac parameters
To investigate cardiac consequences of HFD, non-inva-
sive measurements of cardiac parameters were per-
formed by Doppler echography. Cardiac-diastolic
dysfunction characterized by an elevation of the ratio of
the early mitral flow (E) over the late mitral flow (A)
and LV hypertrophy was observed in some HFD groups.
Thus, a significant increase in E/A ratio by 63% and
59% compared to SD control confirmed diastolic dys-
function in males fed with the VD and AD respectively.
Among females, only the AD group showed an increase
of this ratio compared to control (Table 2), and that by
90%. For its part, LV mass was significantly increased in
the mice fed with VD and AD (24% and 18% in males
and 17% and 14% in females respectively). This increase
of LV mass was essentially caused by the thickness of
the interventricular septum and of the LV posterior wall
(Table 2). Interestingly, the LV hypertrophy in the VD
female group was not associated with diastolic-dysfunc-
tion as observed in the other HFD groups.
Discussion
HFD-induced obesity has become widely accepted as a
key factor of alteration in insulin sensitivity and metabo-
lism [9,11]. However, the physiological regulation and
role of HFD in mediating the unhealthy effects of
increased adiposity remain not fully elucidated.
The novelty of this study is the use of two types of
HFD identical in their lipid proportion but different in
their fat nature. These diets were low in cholesterol in
order to reduce its implication in metabolic alterations
and mimic industrially-produced popular fast food
known as obesity and T2D inducers [9,11,19]. Both
HFD promoted more weight gain than the control SD
with a faster increase in males compared to females.
However, the degrees of metabolic alterations differed
considerably between the two HFD and were highly
influenced by gender. This was not a consequence of
the daily caloric uptake but was rather due to the diet-
ary fat nature and mice gender.
Figure 4 Expression profile of adipokines genes. Adiponectin
(A), leptin (B), PPARg2 (C) and ERa (D) mRNA expression levels in
abdominal visceral white adipose tissue extracted from all groups (n
= 8) were evaluated by Q-PCR. mRNA expression level was reported
as a ratio over the expression level of the reference gene
Cyclophilin-A. * P < 0.05, ** P < 0.01, *** P < 0.001 vs. SD; # P <
0.05, ### P < 0.001 vs. VD.
Table 2 Evaluation of cardiac parameters by Doppler echography
Sex groups Diet groups E/A ratio
± SEM
LV mass (mg)
± SEM
Inter-ventricular septum (mm)
± SEM
LV posterior wall (mm)
± SEM
Male
mice
SD 1.39 ± 0.15 109.8 ± 2.6 0.72 ± 0.01 0.76 ± 0.02
VD 2.27 ± 0.14*** 135.7 ± 7.5 ** 0.83 ± 0.03 ** 0.85 ± 0.02 **
AD 2.20 ± 0.08*** 129.8 ± 6.2 ** 0.89 ± 0.02 *** 0.84 ± 0.01 *
Female
mice
SD 1.56 ± 0.05 101.1 ± 2.7 0.77 ± 0.01 0.70 ± 0.02
VD 1.62 ± 0.08 118.7 ± 5.0 * 0.86 ± 0.03 ** 0.78 ± 0.02 *
AD 3.01 ± 0.45***
### 115.7 ± 3.6 * 0.85 ± 0.03 * 0.79 ± 0.01 **
The early wave (E) and the late wave (A) of the mitral flow. LV mass was calculated by the measurement of the inter-ventricular septum, posterior wall
thicknesses, and the tele-diastolic diameter. * P < 0.05, ** P < 0.01, *** P < 0.001 vs. SD; ### P < 0.001 vs. VD.
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and females under AD showed a more pronounced
accumulation of adipose tissue in the abdominal visceral
region compared to corresponding VD groups. Abdom-
inal visceral adipose tissue mass was slightly increased
in VD group compared to control but remained non
significant when reported as percentage of total body
weight. Thus, despite its implication in increasing weight
gain, a VD promotes a fat mass distribution different
than an AD in both genders. In fact, it is well estab-
lished that mono-unsaturated FA are more accumulated
in the subcutaneous region and prevent central fatty
acid accumulation [20]. Furthermore, it was reported
that postprandial fat oxidation as well as a meal thermic
effect was higher with mono-unsaturated FA rich diet
compared to a saturated FA rich diet [21]. The
increased thermic effect could reflect a pronounced sto-
rage activity of the subcutaneous adipose mass. Thus,
we can speculate that our mono-unsaturated FA rich
diet trigger a different adipose tissue accumulation than
the saturated FA rich AD. However, more experiences
are needed to confirm this hypothesis.
This differential fat accumulation plays a crucial role
in metabolic alterations development. A link was estab-
lished between HOMA-IR increase and the visceral adi-
pose tissue accumulation in AD-fed groups. These
results support previous findings that demonstrate a
correlation between visceral abdominal adipose tissue
accumulation and metabolic alterations; a correlation
not reported for subcutaneous fat accumulation [22,23].
High concentrations of saturated FA such as in AD are
associated with lipotoxicity effects (pancreas, liver, mus-
cle, adipose tissue...) and alter cell membrane dynamics
[24]. This prevents the dimerization of cell surface
receptors such as insulin and leptin receptors and inhi-
bits the signalization of the corresponding hormone.
Therefore, the increased levels of insulin and leptin in
our model could reflect a defect in their respective sig-
nalling pathway. In addition, increased insulin level and
HOMA-IR are obtained simultaneously with enhanced
resistin levels in AD groups. Resistin secretion in adi-
pose tissue is known to induce insulin resistance
through the inhibition of its signalling pathway and the
stimulation of hepatic glucose production [25]. These
data could explain the fact that AD mice developed
increased insulin circulating levels. The VD, rich in
unsaturated FA, did not affect insulin levels nor modu-
lates resistin levels in corresponding groups as reported
in a previous study with unsaturated oleic acid [26]. So,
at similar circulating levels, different combinations of
FA promote distinctive alterations in the systemic glu-
cose homeostasis.
Female mice remained normo-glycemic under HFD
confirming less advancement in metabolic alterations
compared to males. This female-specific resistance to
T2D development was even more striking with VD
compared to AD, which induced hyper-insulinæmia and
slight glucose intolerance. However, VD as well as AD
induced T2D with an increased fasting glycæmia and
glucose intolerance in male mice and that starting the
12
th week of HFD feeding. These alterations could be
correlated with adipocytes death demonstrated in HFD-
fed male mice [27]. This parameter was however never
been investigated in HFD-fed female mice. On the other
hand, our preliminary study didn’t show any increase in
the glycaemia of the HFD-fed female mice even after 16
weeks of diet. We have thus extended our protocol to
20 weeks. It is well established that females show less
extensive metabolic alterations due to the oestrogen
action that protect adipocytes in female from insulin
resistance and inflammation [12,13,28]. In our model,
we have demonstrated that females had a higher level of
ERa mRNA in their adipocytes. Its mRNA expression
level could reflect a higher activity of ERa in corre-
sponding tissue. Furthermore, recent evidence shows
that FA accumulation is more oriented to the visceral
fat pad in male while it is more directed to the periph-
eral region [29]. Thus, since android fat accumulation is
more associated to metabolic alterations development
[22], these observations could explain the prevention of
T2D development in female groups.
Both HFD increased leptin levels in male and female
mice with a significant difference between VD and AD
groups. Correlated with body weight increase, high cir-
culating leptin levels, known to improve glucose home-
ostasis [30], suggests leptin resistance in obese mice.
Leptin resistance affects glucose homeostasis and contri-
butes directly to hyperglycaemia [30,31]. Male mice
showed increased leptin levels concurrently with
increased AUC values of the IPGTT. In female groups,
the apparent lack of negative leptin action on glycaemia
could be due to a counterbalanced effect by the high
adiponectin levels compared to male groups. Adiponec-
tin, an insulin-sensitizer adipokine and an inhibitor of
hepatic glucose production, contributes to improved
glucose homeostasis [32,33].
To evaluate the direct impact of diets on adipose tis-
sue, additional analyses were performed at the mRNA
level. TNFa is a key regulator of the adipogenesis that
decreases insulin sensitivity and promotes free FA pro-
duction by stimulating lipolysis and inhibiting the antili-
polytic effects of insulin [34,35]. In our model, TNFa
mRNA levels in visceral abdominal adipose tissue were
increased in males under AD and, to a much lesser
extent, in VD-fed males. This effect could be due to
enhanced macrophage infiltration in the adipose tissue
[27,35,36]. In the AD group, it was associated with lep-
tin and resistin circulating levels known to augment
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may have contributed to limit TNFa up-regulation. This
FA was found to be effective in reversing the inflamma-
tory status in adipose tissue responsible for decreased
insulin sensitivity [36]. In the AD female group, despite
their increased levels of leptin and resistin, TNFa
mRNA levels remained unchanged in the visceral adi-
pose tissue. A high level of circulating adiponectin is
known to inhibit TNFa effects [39,40]. Adiponectinemia
in HFD-fed group was reduced in female mice com-
pared to control. However, these levels of adiponectin
seem to still be enough to prevent TNFa mRNA up reg-
ulation in the adipose tissue. Moreover, it could also
have contributed to the delay of T2D development
regardless of high leptin levels [40]. However, decreased
mRNA expression levels of adiponectin in the adipose
tissue of females under HFD could be the first sign of
progression toward a metabolic alteration cascade.
Thus, adiponectin modulation seems to play a critical
role in our model and could contribute to differences
between males and females, with delayed metabolic
alterations in the latter.
Hyperplasia and hypertrophy of adipocytes are
involved in obesity [41]. The balance between the two
processes is controlled by FA nature that governs
nuclear receptors activity [42]. Therefore, inhibition of
adipogenesis through high levels of circulating FA trig-
gers adipocytes hypertrophy and leads to insulin resis-
tance [43], a situation encountered in the AD mice
group. In contrast with the oleic-rich VD-fed groups,
metabolic alterations were less extensive with an
absence of hyper-insulinæmia. In this case, adipocyte
hypertrophy and hyperplasia occurred. Hyperplasic obe-
sity is accepted as being less harmful regarding meta-
bolic alterations and adipose tissue inflammation
[35,36].
Dietary FA modulate PPARg activity which controls
adipokines secretion [43,44]. Superior adipogenesis
potential in white adipose tissue of the abdominal visc-
eral region of females over males is suggested by the
pattern of expression levels of the PPARg2 gene. Our
results showed decreased levels of PPARg2m R N Ai n
HFD groups and remained higher in females compared
to males. The highest levels were found in the VD
female group protected against HFD-mediated negative
metabolic impacts. These results support the hypothesis
about the role of PPARg2 in preventing adipocytes
hypertrophy that leads to decrease adiponectin circulat-
ing levels and insulin sensitivity.
In previous studies, crosstalk between the estrogens
receptors and PPARg regulatory pathways has been
demonstrated with sex hormone regulation of adipokine
production [16,42]. Expression of ERa, a main mediator
of oestrogen effects, was investigated as it could be
involved in the gender regulation and/or diet-specific
response of adipose tissue. In this study, ERa mRNA
levels in adipocytes were decreased with HFD but
remained higher in female groups. Such higher expres-
sion levels of ERa in females may favour PPARg2
mRNA expression under HFD when compared to males
[16].
Signs of cardiac diastolic dysfunction linked to weight
gain and metabolic alterations were also detected in the
HFD groups. An increase of the E/A ratio, with restric-
tive aspects of transmitral flow (E/A > 2), indicated a
diastolic dysfunction with increased LV filling pressure.
A significant elevation of the E/A ratio occurred in
males fed with the VD or AD (63% and 59%, respec-
tively) and a 90% increase in the AD female group only.
Females on VD had no modification of the E/A ratio
despite being overweight. Obesity can be associated with
impaired LV diastolic function [45] though the exact
reason is still unclear. Leptin regulation of the hypotha-
lamic-pituitary-adrenal axis responsible for blood pres-
sure regulation [31], is disturbed in obese subjects.
Thus, high leptin concentration leads to diastolic dys-
function associated with higher cardiac sympatic ner-
vous system activity and increased LV mass [45]. This
dysfunction with a reduction in cardiac compliance was
associated with LV dilatation and an increased LV mass
in HFD groups.
Hyperglycaemia and hyper-insulinæmia have also been
suggested to be additive stimuli to LV hypertrophy [46].
Thus, the fasting hyperglycaemia in male mice under
HFD and the elevated level of circulating insulin in mice
under AD could have aggravated cardiac hypertrophy
and alteration. In fact, in glucose diabetic and insulin
resistant mice, the myocardium consumes more FA to
produce energy leading to more LV hypertrophy. Female
mice under VD increased their LV mass without diasto-
lic dysfunction. The normal glycemic and insulin rates
in the presence of higher adiponectin concentration
compared to the male group contributed to maintain
normal diastolic function. Furthermore, the VD contains
27% more oleic acid, which is known to prevent cardiac
dysfunctions [47], than the AD. These differences in diet
composition could explain the prevention of diastolic
dysfunction in the female VD group but not in the
female AD group.
Metabolic alterations development is different between
males and females. However, the majority of studies on
HFD-induced metabolic disorders are restricted to
males [48]. The strength of this work was therefore the
evaluation of the respective sensitivity of both sexes to
two types of low-cholesterol HFD, differing in their diet-
ary FA nature. Thus, we have shown that combinations
of FA have gender-related effects on visceral fat distri-
bution and metabolic consequences. Therefore,
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reflected by sex hormone-associated modulation of adi-
ponectin production, TNFa and PPARg regulation in
visceral adipose tissue. However, further investigation
will be required to explain the differences in response to
the two types of HFD among females.
Understanding gender-specific adipose tissue adapta-
tions underlying metabolic disorders linked to HFD and
unhealthy lifestyles will considerably contribute to the
development of improved strategies for the prevention
and treatment of metabolic and cardiovascular diseases.
Conclusions
Combinations of FA have gender-related effects on visc-
eral fat distribution and metabolic consequences. Sus-
ceptibility to develop HFD-linked T2D is strongly
reflected by gender modulation of adiponectin produc-
tion, TNFa and PPARg regulation in visceral adipose
tissue. The evaluation of the hormone modulations in
our mice model could provide more answers on the
remained unclear sex differences.
Additional material
Additional file 1: Additional data. This file contains a table (Additional
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figure S1) reporting the TNFa gene expression profile.
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